Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Therapy Related Myelodysplastic Syndrome and Acute Myeloid Leukaemia (tMDS/tAML) in Patients Treated with Purine Analogues (PA) for Lymphoproliferative Disorders (LPD); An Association with Alkylator Combination, Dose and Previous Alkylator Therapy.

Pallavi Kalkur, MRCP, Stella J Bowcock, FRCP, FRCPath, Anand Sharma, MRCP, Evangelia Dimitriadou, Ghulam J Mufti, MBBS, DM, FRCP, FRCPath, Saad M.B. Rassam, MD, FRCP, FRCPath

Blood (2009) 114 (22): 3828.

https://doi.org/10.1182/blood.V114.22.3828.3828

Published: 2009

Journal Articles

Rapid and Excellent Response to Hyper CVAD, Particularly with Thalidomide, in Plasma Cell Leukaemia and Long Term Remissions Following Allogeneic Stem Cell Transplantation.

Vidhya Murthy, Anne Mwirigi, Susan Ward, Saad M.B. Rassam, MD, FRCP, FRCPath

Blood (2009) 114 (22): 4963.

https://doi.org/10.1182/blood.V114.22.4963.4963

Published: 2009

Journal Articles

Fanconi-Like Syndrome with Negative Chromosomal Breakages Test and High Incidence of Myelodysplasia.

Sunil Gupta, MD, Saad M.B. Rassam, MD, Madan Riyali, MD, Aloysius Y.L. Ho, MD, Ghulam Mufti, MD

Blood (2007) 110 (11): 1681.

https://doi.org/10.1182/blood.V110.11.1681.1681

Published: 2007

Journal Articles

Eradication of Minimal Residual Disease with Alemtuzumab in Chronic Lymphocytic Leukemia Is Associated with Prolonged Survival and Is an Appropriate Theraputic Endpoint for Relapsed CLL.

Hazem A. Sayala, Paul Moreton, Ben Kennedy, Guy Lucas, Michael Leach, Saad M.B. Rassam, Andrew Haynes, Jane Tighe, David G. Oscier, Christopher Fegan, Andy C. Rawstron, Peter Hillmen

Blood (2007) 110 (11): 3114.

https://doi.org/10.1182/blood.V110.11.3114.3114

Published: 2007

Journal Articles

Leukaemic Monocytoid Marginal Zone Lymphoma (LMMZL): A Rare Undescribed Lymphoproliferative Disorder with Unique Features.

Lara N. Roberts, Madan M. Ryali, Stella J. Bowcock, Susan M. Ward, Richard Gale, Saad M.B. Rassam

Blood (2007) 110 (11): 4424.

https://doi.org/10.1182/blood.V110.11.4424.4424

Published: 2007

NARROW

Therapy Related Myelodysplastic Syndrome and Acute Myeloid Leukaemia (tMDS/tAML) in Patients Treated with Purine Analogues (PA) for Lymphoproliferative Disorders (LPD); An Association with Alkylator Combination, Dose and Previous Alkylator Therapy.

Rapid and Excellent Response to Hyper CVAD, Particularly with Thalidomide, in Plasma Cell Leukaemia and Long Term Remissions Following Allogeneic Stem Cell Transplantation.

Fanconi-Like Syndrome with Negative Chromosomal Breakages Test and High Incidence of Myelodysplasia.

Eradication of Minimal Residual Disease with Alemtuzumab in Chronic Lymphocytic Leukemia Is Associated with Prolonged Survival and Is an Appropriate Theraputic Endpoint for Relapsed CLL.

Leukaemic Monocytoid Marginal Zone Lymphoma (LMMZL): A Rare Undescribed Lymphoproliferative Disorder with Unique Features.

Email alerts

ASH Publications

American Society of Hematology

Therapy Related Myelodysplastic Syndrome and Acute Myeloid Leukaemia (tMDS/tAML) in Patients Treated with Purine Analogues (PA) for Lymphoproliferative Disorders (LPD); An Association with Alkylator Combination, Dose and Previous Alkylator Therapy.

Rapid and Excellent Response to Hyper CVAD, Particularly with Thalidomide, in Plasma Cell Leukaemia and Long Term Remissions Following Allogeneic Stem Cell Transplantation.

Fanconi-Like Syndrome with Negative Chromosomal Breakages Test and High Incidence of Myelodysplasia.

Eradication of Minimal Residual Disease with Alemtuzumab in Chronic Lymphocytic Leukemia Is Associated with Prolonged Survival and Is an Appropriate Theraputic Endpoint for Relapsed CLL.

Leukaemic Monocytoid Marginal Zone Lymphoma (LMMZL): A Rare Undescribed Lymphoproliferative Disorder with Unique Features.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only